2007•Zhongguo yiyuan yongyao pingjia yu fenxiRequires access

Bioequivalence of Isosorbide Mononitrate Sustained Tablets in Chinese Healthy Volunteers

JI Hong-ying

Open publisher page 0 citations

Abstract

OBJECTIVE:To evaluate the bioequivalence of two kinds of isosorbide mononitrate sustained tablets in Chinese healthy volunteers.METHODS:According to two formulas double period crossover protocol,a total of 18 healthy volunteers were orally administered with test prepartion(T)or reference preparation(R)(40mg),1w later,they were administered with R or T by a crossover way.For multidoese trial,the patients received T or R 40mg every morning for 6 consecutive days.Blood samples were taken at 4-6 days before oral administration in the morning,and according to the protocal,the blood samples were taken at 6d after oral administration.Serum concentrations of isosorbide mononitrate were measured with validated GC-ECD.The pharmacokinetic parameters and bioavailability of two isosorbide mononitrate sustained tablets were calculated and the bioequivalence was evaluated.RESULTS:The main pharmacokinetic parameters of tested and reference isosorbide mononitrate sustained tablet in volunteers administrated with an oral single dose of 40mg were as follows:T max(4.9±1.6)and(4.9±1.2)h,C max(719.42±183.72)and(726.52±177.55)ng·mL-1,t_ 1/2(3.9±0.6)and(3.7±0.9)h,AUC_ 0-t(5 687.38±1 271.64)and(5 586.05±1 290.01)ng·h·mL-1,AUC_ 0-∞(5 831.67± 1 308.47)and(5 719.20±1 329.54)ng·h·mL-1,and computed based on AUC_ 0-t,the relative bioavailability of tested isosorbide mononitrate sustained tablet was(103.0±17.1)%.The main pharmacokinetic parameters of tested and reference isosorbide mononitrate sustained tablet in volunteers administrated with oral multi-dose of 40 mg were as follows:T max-ss(4.9±1.4)and(4.9±1.5)h,C max-ss(745.43±143.83)and(747.55±130.72)ng·mL-1,AUC ss(7 860.24± 1 827.46)and(8 104.13±1 637.35)ng·h·mL-1,and the relative bioavailability of tested isosorbide mononitrate sustained tablet was(97.1±10.9)%.Tested with Wilcoxon(T max),ANOVA and two one-sided t test(AUC,C max),the main pharmacokinetic parameters of tested and reference isosorbide mononitrate sustained tablets showed no significant differences.The 90% confidential intervals of C max and AUC_ 0-t of tested formula were 93.26%~104.33% and 95.10%~108.83%,respectively.The 90% confidential intervals of C max-ss and AUC ss of tested formula were 93.97%~105.01% and 92.24%~101.08%,respectively.CONCLUSION:Two kinds of isosorbide mononitrate sustained tablets are bioequivalent.

About this research paper

What this paper is about

OBJECTIVE:To evaluate the bioequivalence of two kinds of isosorbide mononitrate sustained tablets in Chinese healthy volunteers.METHODS:According to two formulas double period crossover protocol,a total of 18 healthy volunteers were orally administered with test prepartion(T)or reference preparation(R)(40mg),1w later,they were administered with R or T by a crossover way.For multidoese trial,the patients received T or R 40mg every morning for 6 consecutive days.Blood samples were taken at 4-6 days before oral administration in the morning,and according to the protocal,the blood samples were taken at 6d after oral administration.Serum concentrations of isosorbide mononitrate were measured with validated GC-ECD.The pharmacokinetic parameters and bioavailability of two isosorbide mononitrate sustained tablets were calculated and the bioequivalence was evaluated.RESULTS:The main pharmacokinetic parameters of tested and reference isosorbide mononitrate sustained tablet in volunteers administrated with an oral single dose of 40mg were as follows:T max(4.9±1.6)and(4.9±1.2)h,C max(719.42±183.72)and(726.52±177.55)ng·mL-1,t_ 1/2(3.9±0.6)and(3.7±0.9)h,AUC_ 0-t(5 687.38±1 271.64)and(5 586.05±1 290.01)ng·h·mL-1,AUC_ 0-∞(5 831.67± 1 308.47)and(5 719.20±1 329.54)ng·h·mL-1,and computed based on AUC_ 0-t,the relative bioavailability of tested isosorbide mononitrate sustained tablet was(103.0±17.1)%.The main pharmacokinetic parameters of tested and reference isosorbide mononitrate sustained tablet in volunteers administrated with oral multi-dose of 40 mg were as follows:T max-ss(4.9±1.4)and(4.9±1.5)h,C max-ss(745.43±143.83)and(747.55±130.72)ng·mL-1,AUC ss(7 860.24± 1 827.46)and(8 104.13±1 637.35)ng·h·mL-1,and the relative bioavailability of tested isosorbide mononitrate sustained tablet was(97.1±10.9)%.Tested with Wilcoxon(T max),ANOVA and two one-sided t test(AUC,C max),the main pharmacokinetic parameters of tested and reference isosorbide mononitrate sustained tablets showed no significant differences.The 90% confidential intervals of C max and AUC_ 0-t of tested formula were 93.26%~104.33% and 95.10%~108.83%,respectively.The 90% confidential intervals of C max-ss and AUC ss of tested formula were 93.97%~105.01% and 92.24%~101.08%,respectively.CONCLUSION:Two kinds of isosorbide mononitrate sustained tablets are bioequivalent.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

OBJECTIVE:To evaluate the bioequivalence of two kinds of isosorbide mononitrate sustained tablets in Chinese healthy volunteers.METHODS:According to two formulas double period crossover protocol,a total of 18 healthy volunteers were orally administered with test prepartion(T)or reference preparation(R)(40mg),1w later,they were administered with R or T by a crossover way.For multidoese trial,the patients received T or R 40mg every morning for 6 consecutive days.Blood samples were taken at 4-6 days before oral administration in the morning,and according to the protocal,the blood samples were taken at 6d after oral administration.Serum concentrations of isosorbide mononitrate were measured with validated GC-ECD.The pharmacokinetic parameters and bioavailability of two isosorbide mononitrate sustained tablets were calculated and the bioequivalence was evaluated.RESULTS:The main pharmacokinetic parameters of tested and reference isosorbide mononitrate sustained tablet in volunteers administrated with an oral single dose of 40mg were as follows:T max(4.9±1.6)and(4.9±1.2)h,C max(719.42±183.72)and(726.52±177.55)ng·mL-1,t_ 1/2(3.9±0.6)and(3.7±0.9)h,AUC_ 0-t(5 687.38±1 271.64)and(5 586.05±1 290.01)ng·h·mL-1,AUC_ 0-∞(5 831.67± 1 308.47)and(5 719.20±1 329.54)ng·h·mL-1,and computed based on AUC_ 0-t,the relative bioavailability of tested isosorbide mononitrate sustained tablet was(103.0±17.1)%.The main pharmacokinetic parameters of tested and reference isosorbide mononitrate sustained tablet in volunteers administrated with oral multi-dose of 40 mg were as follows:T max-ss(4.9±1.4)and(4.9±1.5)h,C max-ss(745.43±143.83)and(747.55±130.72)ng·mL-1,AUC ss(7 860.24± 1 827.46)and(8 104.13±1 637.35)ng·h·mL-1,and the relative bioavailability of tested isosorbide mononitrate sustained tablet was(97.1±10.9)%.Tested with Wilcoxon(T max),ANOVA and two one-sided t test(AUC,C max),the main pharmacokinetic parameters of tested and reference isosorbide mononitrate sustained tablets showed no significant differences.The 90% confidential intervals of C max and AUC_ 0-t of tested formula were 93.26%~104.33% and 95.10%~108.83%,respectively.The 90% confidential intervals of C max-ss and AUC ss of tested formula were 93.97%~105.01% and 92.24%~101.08%,respectively.CONCLUSION:Two kinds of isosorbide mononitrate sustained tablets are bioequivalent.

Key concepts: Bioequivalence, Isosorbide mononitrate, Bioavailability, Pharmacokinetics, Medicine, Crossover study, Oral administration, Pharmacology

Related papers

Back to paper searchBrowse research topicsOriginal source
Bioequivalence of Isosorbide Mononitrate Sustained Tablets in Chinese Healthy Volunteers — Research Paper | ScholarLens